Publications of Tiago Fleming Outeiro
All genres
Journal Article (133)
2025
Journal Article
136, 107850 (2025)
Alpha-synuclein in Parkinson's disease: the debate that must go on. Parkinsonism & Related Disorders
Journal Article
Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions. Molecular Neurobiology (2025)
Journal Article
14, 22 (2025)
Stress granules: emerging players in neurodegenerative diseases. Translational Neurodegeneration
Journal Article
Neural and vascular contributions to sensory impairments in a human alpha-synuclein transgenic mouse model of Parkinson’s disease. Journal of Cerebral Blood Flow and Metabolism (2025)
Journal Article
289, 117452 (2025)
Rationally designed peptides inhibit the formation of α-synuclein fibrils and oligomers. European Journal of Medicinal Chemistry
Journal Article
377, 144348 (2025)
The neurotoxicity of pesticides: Implications for Parkinson's disease. Chemosphere
Journal Article
20, 34 (2025)
A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies. Molecular Neurodegeneration
Journal Article
16 (6), pp. 1034 - 1042 (2025)
Inhibition of the Parkinson’s Disease-Related Protein DJ-1 by Endogenous Neurotoxins of the 1,2,3,4-Tetrahydroisoquinoline Family. ACS Chemical Neuroscience
Journal Article
Expanding our understanding of synucleinopathies: proteinopathy, proteinopenia, and lipidopathy. The FEBS Journal (2025)
Journal Article
16 (4), pp. 687 - 698 (2025)
Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach. ACS Chemical Neuroscience
Journal Article
Protein misfolding: understanding biology to classify and treat synucleinopathies. Journal of Neural Transmission (2025)
Journal Article
21 (2), e14449 (2025)
Initial biological classification of Lewy body diseases: No consensus on terminology. Alzheimer's & Dementia
Journal Article
268, 116880 (2025)
α-Synuclein plastic antibody applied to monitor monomeric structures and discriminate aggregated forms in human CSF. Biosensors and Bioelectronics
Journal Article
476, 115269 (2025)
Correlational assessment of the effects of JM-20 in a rat model of parkinsonism. Behavioural Brain Research
Journal Article
7 (2), fcaf133 (2025)
Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis. Brain Communications 2024
Journal Article
131, 103969 (2024)
SUMOylation modulates mitochondrial dynamics in an in vitro rotenone model of Parkinson's disease. Molecular and Cellular Neuroscience
Journal Article
13 (11), 939 (2024)
Dose-Dependent Cognitive Decline, Anxiety, and Locomotor Impairments Induced by Doxorubicin: Evidence from an Animal Model. Biology
Journal Article
64 (21), pp. 8215 - 8226 (2024)
Impact of Phosphorylation on the Physiological Form of Human alpha-Synuclein in Aqueous Solution. Journal of Chemical Information and Modeling
Journal Article
8 (1), pp. 83 - 98 (2024)
Stress granules formation in HEI-OC1 auditory cells and in H4 human neuroglioma cells secondary to cisplatin exposure. Cell Stress
Journal Article
25 (20), e202400253 (2024)
Synthesis and Semi-Synthesis of Alpha-Synuclein: Insight into the Chemical Complexity of Synucleinopathies. Chembiochem